Evaluation of Amiodarone Use for New-Onset Atrial Fibrillation in Critically Ill Patients With Septic Shock

Evaluation of Amiodarone Use for New-Onset Atrial Fibrillation in Critically Ill Patients With Septic Shock

Objective: To describe the use of amiodarone in critically ill, septic shock patients experiencing new-onset atrial fibrillation (NOAF) during the acute resuscitative phase of septic shock. Methods: Single-center, retrospective review of adult medical or surgical intensive care unit (ICU) patients w...

Full description

Bibliographic Details
Main Authors: Betthauser, K.D (Author), Gibson, G.A (Author), Piche, S.L (Author), Pope, H.E (Author)
Format: Article
Language:English
Published: SAGE Publications Ltd 2021
Subjects:
adult
aged
amiodarone
antibiotic agent
antibiotic therapy
APACHE
Article
artificial ventilation
atrial fibrillation
beta adrenergic receptor blocking agent
calcium channel blocking agent
cardiac surgery intensive care unit
cardioversion
Charlson Comorbidity Index
clinical outcome
cohort analysis
continuous infusion
controlled study
coronary care unit
critically ill patient
digoxin
disease association
dobutamine
dopamine
drug dose reduction
drug use
epinephrine
female
hemodialysis
hospital discharge
hospitalization
human
infusion fluid
in-hospital mortality
intensive care unit
length of stay
lung infection
magnesium
magnesium blood level
major clinical study
male
medical intensive care unit
medical record review
milrinone
new-onset atrial fibrillation
noradrenalin
pharmacology
phenylephrine
potassium
potassium blood level
retrospective study
septic shock
surgical intensive care unit
survivor
vasoactive agent
vasopressin
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items